IRAK4-IN-26 (Compound 21), an IRAK4 inhibitor with an IC50 of 6.2 nM, exhibits an oral bioavailability of 21%. It is utilized for the study of inflammatory and autoimmune disorders [1].
Molecular Weight:
405.45
Formula:
C22H23N5O3
Target:
IRAK
* VAT and and shipping costs not included. Errors and price changes excepted
